about
Experimental modulation of capsule size in Cryptococcus neoformansFungal cell gigantism during mammalian infectionRegulatory elements in the FBP1 promoter respond differently to glucose-dependent signals in Saccharomyces cerevisiaeAntifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profileParadoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.Fungemia due to rare opportunistic yeasts: data from a population-based surveillance in Spain.Capsule growth in Cryptococcus neoformans is coordinated with cell cycle progression.Cryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection.It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drugThe production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.Frequency of voriconazole resistance in vitro among Spanish clinical isolates of Candida spp. According to breakpoints established by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing.Process analysis of variables for standardization of antifungal susceptibility testing of nonfermentative yeasts.Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport.Role of Cln1 during melanization of Cryptococcus neoformans.Recurrent episodes of candidemia due to Candida glabrata with a mutation in hot spot 1 of the FKS2 gene developed after prolonged therapy with caspofunginCryptococcus neoformans induces antimicrobial responses and behaves as a facultative intracellular pathogen in the non mammalian model Galleria mellonellaCell Wall Changes in Amphotericin B-Resistant Strains from Candida tropicalis and Relationship with the Immune Responses Elicited by the HostBiofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.Erratum for Marcos-Zambrano et al., Comparison between the EUCAST Procedure and the Etest for Determination of the Susceptibility of Candida Species Isolates to MicafunginCandida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications.Update on the epidemiology and diagnosis of invasive fungal infection.The capsule of the fungal pathogen Cryptococcus neoformans.Susceptibility profile of clinical isolates of non-Cryptococcus neoformans/non-Cryptococcus gattii Cryptococcus species and literature review.New Panfungal Real-Time PCR Assay for Diagnosis of Invasive Fungal Infections.In vitro activity of antifungals against Zygomycetes.A multiplex real-time PCR assay for identification of Pneumocystis jirovecii, Histoplasma capsulatum, and Cryptococcus neoformans/Cryptococcus gattii in samples from AIDS patients with opportunistic pneumonia.Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans.Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates.Fungal morphogenetic changes inside the mammalian host.Role of catalase overproduction in drug resistance and virulence in Candida albicans.A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains.Isolation of the MIG1 gene from Candida albicans and effects of its disruption on catabolite repression.Capsule Enlargement in Cryptococcus neoformans Is Dependent on Mitochondrial Activity.Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia.Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia.The formation of titan cells in Cryptococcus neoformans depends on the mouse strain and correlates with induction of Th2-type responses.Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans.Expanding the use of alternative models to investigate novel aspects of immunity to microbial pathogens.Corrigendum: Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates.Elements from the cAMP signaling pathway are involved in the control of expression of the yeast gluconeogenic gene FBP1.
P50
Q24805267-2A65E917-D22E-43E5-93D6-23358B838079Q27314614-2714F22D-3ECE-428B-AA0B-FB23BCA7B133Q28355627-667BB8AE-B46C-4065-B5D9-B0EB1A0EFFDFQ28489096-CACE7D6E-D187-4AD6-ABEF-E0C0B09D286AQ30570494-0101307A-5787-49A0-B101-7A5CA0A9023BQ31119810-41DBABFD-712A-45E4-94DF-D7262C2283B6Q33751817-D88DF1CC-DB12-43E7-B582-8446FF060BC3Q34019066-1E197F8E-C112-400F-AE6B-F002AEB65743Q34302880-91A29BBF-DBB2-45F1-828D-3377B3A67128Q34596780-75D2DA51-BDC5-416C-AF22-B3D45F4B3259Q34737476-A700E0D0-58E7-4CA3-85FB-1B31EA2DAE96Q34737873-B3BB57BE-2CD4-4891-958E-3A0440320F71Q35641043-EE8ABB53-A97A-4B49-B996-415EFBC3055CQ35942002-4AD92AFE-893E-468C-8C8D-9E6135B0E777Q36018829-12048FCE-1825-4CF0-AF06-BBC5A2B73BABQ36154961-38C62FB2-6FCE-44DE-B8F7-FC745D91EC7EQ36729978-F8990C23-1157-4E73-990B-08032F39281DQ36933366-244E5DF4-6106-4E8D-8AA2-885ED59DDA8DQ37023317-6B047015-240B-4FCA-B80D-7C77CD24824BQ37263791-393AAAF8-9EBD-4C47-8C73-254DA95A38DFQ37327092-164C3542-36C7-424C-ACCE-B772E0B283FDQ37337879-864D3D9B-E7DC-4E59-BACC-4C72057B655FQ37398908-35369BB1-D3D2-4B3B-8894-BB9F8EED0E41Q37434286-AA8654C1-090E-43FE-A3BD-4B72A1E0A92EQ37597559-68D8E187-2473-4B72-825D-1855A092D6E5Q37713483-61934F52-8DE9-48F7-8BA0-302EDD7E1E0BQ37949657-EF752A5A-9ABD-4FF9-AB41-1FD2A7708884Q38467366-806EE5FD-4229-4C2C-9BC6-D7CACABCBB43Q38814194-B2BFEF40-D701-43C5-87CC-2F9B3344C3A3Q38815901-FFE28DAF-9C4D-41C7-A6AF-3B838F37950CQ39029924-E4171F4D-EBB6-4FC5-B47B-A3EAE4CB4722Q39498517-0B617DEA-FC64-427A-B5F4-B7F6A7752DA1Q40086468-946EC162-8493-4AC4-AD87-3B736CD59ED5Q40239343-B5422F42-8BA6-4A45-BE7F-2A35707D6B4BQ40525563-265B54D3-3963-426C-964D-A48B525B4937Q41071866-F77212FA-0B48-44B4-8E2A-6725E688FCAAQ41096721-9B9B16AE-7B61-424C-9527-0DF977C8D8BEQ42702753-BE268097-2B23-41A5-BD7D-74B3BF1EAE4BQ42868649-56B4014D-D8EF-4776-B774-E22D715B0654Q43767661-FDCE919B-1856-44BB-A4BA-091E8FE66882
P50
description
researcher ORCID ID = 0000-0002-1581-0845
@en
wetenschapper
@nl
name
Oscar Zaragoza
@ast
Oscar Zaragoza
@en
Oscar Zaragoza
@es
Oscar Zaragoza
@nl
type
label
Oscar Zaragoza
@ast
Oscar Zaragoza
@en
Oscar Zaragoza
@es
Oscar Zaragoza
@nl
prefLabel
Oscar Zaragoza
@ast
Oscar Zaragoza
@en
Oscar Zaragoza
@es
Oscar Zaragoza
@nl
P1153
6603872053
P31
P496
0000-0002-1581-0845